The expansion increases output, enhancing Axplora’s ability to meet growing global demand for high-value pharmaceutical ...

Developed by Autolus Therapeutics, AUCATZYL is approved to treat adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (r/r B-ALL). This follows prior authorizations from ...